On 17th September 2018, Sarah Garner, coordinator of the Innovation, Access and Use team under the Essential Medicines and Health Products program, World Health Organization, had an informal meeting at the Health Intervention and Technology Assessment Program (HITAP). She was eager to learn about HI

HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

(Reuters) – Sanofi’s rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.The withdrawal, meant to prevent the off-label use of Campath as a multiple sclerosis drug, is al

Vietnam visit 30th and 31st May 2017It feels good to see familiar faces when you are in a new place and I felt the same meeting officials from Health Strategy Planning Institution (HSPI), Ministry of Health of Vietnam once again. I had met them earlier during the HTAsiaLink conference held in April

I (the author of the blog) got to learn a lot about three things while discussions on these potential topics were on-going. Firstly, I got to know the uniqueness of the Vietnamese Health System and how they are trying to incorporate HTA and pharmacoeconomics in their current system, secondly I learn

Before the pandemic, many countries recognized the importance of regional collaboration in preparing for future pandemics, whether within ASEAN or the broader Asua Pacific region. In 2019, the SSHSPH discussed with the DFAT Australia for funding and support to this initiative, and the onset of the p

Yot Teerawattananon programme leader1, Alia Luz project associate2, Churnrurtai Kanchanachitra director, Mahidol University Global Health 3, Sripen Tantivess senior researcher 1, On behalf of the Prince Mahidol Award Conference secretariat 1Health Intervention and Technology Assessment Program (

Rojarek Leksomboon Project Coordinator in the Administration Unit graduated from the Faculty of Business Administration, Accounting, Rajamangala Institute of Technology.ExperienceFinance and Accounting Analyst, Institute of Nutrition, Mahidol UniversityAccountant and Human Resource, National Health FoundationAccountant and Human Resource, Internati

Cases of drug-resistant tuberculosis (TB) in the UK have risen by over a quarter in the last year, the Health Protection Agency (HPA) has revealed.In 2011, 431 cases did not respond to antibiotic treatment compared to 342 in 2010, the HPA said. About 550 more cases of TB were disgnosed in 2011.The a

Abstract Thailand is encountering challenges to introduce the high-cost sofosbuvir for chronic hepatitis C treatment as part of the Universal Health Care’s benefit package. This study was conducted in respond to policy demand from the Thai government to assess the value for money and budget impac